Recombinant Protein Immunizes Mice, Promises New Strategy Against Infection and Cancer
Whitehead Institute for Biomedical ResearchSolving a long-standing problem in vaccine development, scientists have crafted a new way to deliver foreign proteins into the body such that the immune system is primed to attack virus-infected cells and cancer cells. Because this kind of an immune response is key to vaccine development, the findings have profound implications for developing safe vaccines to immunize against AIDS and other infectious diseases, and for creating new cancer therapies.